NOROVIRUS ACUTE GASTROENTERITIS
Clinical trials for NOROVIRUS ACUTE GASTROENTERITIS explained in plain language.
Never miss a new study
Get alerted when new NOROVIRUS ACUTE GASTROENTERITIS trials appear
Sign up with your email to follow new studies for NOROVIRUS ACUTE GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive trial launches for first mRNA norovirus vaccine
⭐️ VACCINE ⭐️ OngoingThis study tests an experimental mRNA vaccine (mRNA-1403) to prevent norovirus, a highly contagious virus that causes vomiting and diarrhea. About 38,000 adults aged 18 and older will receive either the vaccine or a placebo. The goal is to see if the vaccine safely reduces cases …
Matched conditions: NOROVIRUS ACUTE GASTROENTERITIS
Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 13:57 UTC
-
MRNA vaccine aims to stop vomiting bug in its tracks
⭐️ VACCINE ⭐️ OngoingThis study tests two experimental mRNA vaccines (mRNA-1403 and mRNA-1405) to see if they can prevent norovirus, a highly contagious virus that causes severe vomiting and diarrhea. About 1,400 healthy adults aged 18 to 80 will receive either a vaccine or a placebo. Researchers wil…
Matched conditions: NOROVIRUS ACUTE GASTROENTERITIS
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:02 UTC